神经炎症
神经退行性变
炎症体
刺
多巴胺能
MPTP公司
药理学
促炎细胞因子
神经科学
医学
生物
免疫学
炎症
多巴胺
内科学
疾病
航空航天工程
工程类
作者
Baozhu Wang,Yanwei Wang,Jingru Qiu,Shixuan Gao,Shuyan Yu,Deqing Sun,Haiyan Lou
标识
DOI:10.1016/j.intimp.2023.110827
摘要
Abstract Background Parkinson's disease (PD) is a progressive neurodegenerative movement disorder characterized by the loss of nigrostriatal dopaminergic neurons and chronic neuroinflammation. However, the mechanisms linking chronic neuroinflammation to dopaminergic neuronal death have not been completely elucidated. Recent emerging evidence reveals that the cGAS-STING-mediated Type I interferon (IFN) signaling axis takes part in the microglial-associated neuroinflammation. However, the potential role of pharmacological inhibition of STING on neuroinflammation and thus the dopaminergic neurodegeneration is largely unknown. Methods In vitro, the effects of pharmacological inhibition of STING on LPS/MPP+-induced inflammatory responses in BV2 microglial cells were determined by real time RT-PCR and western blot analysis. For the in vivo studies, the acute and sub-acute mice models of PD were established by intraperitoneal injection of 1-methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydrophine (MPTP). The selective STING inhibitor C-176 was administered by intraperitoneal injection. The potential protective effects of C-176 on dopaminergic neurons and neuroinflammation were evaluated by behavioral test, tyrosine hydroxylase (TH) immunostaining, Nissl staining, western blotting, qPCR and immunofluorescence. Results We report that STING levels were upregulated in MPTP-induced PD mice model. Therapeutic inhibition of STING with C-176 significantly inhibited the activation of downstream signaling pathway, suppressed associated neuroinflammation, and ameliorated MPTP-induced dopaminergic neurotoxicity and motor deficit. Furthermore, pharmacological inhibition of STING within BV2 microglia which treated with LPS/MPP+ leads to decreased inflammatory responses. More importantly, C176 also reduced NLRP3 inflammasome activation both in vitro and in vivo. Conclusion The results of our study suggest that pharmacologic inhibition of STING protects against neuroinflammation that may act at least in part through suppressing NLRP3 inflammasome activation and thus ameliorated dopaminergic neurodegeneration. STING signaling may holds great promise for the development of new treatment strategy for PD as an effective therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI